HemoShear Therapeutics logo

HemoShear Therapeutics

Developing new treatments for rare metabolic disorders

27 employees · est. 2008 · Charlottesville, United Stat...

VS
Rubedo Life Sciences logo

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging

32 employees · est. 2018 · Sunnyvale, United States

HemoShear Therapeutics is the older company (2008 vs 2018).

Side-by-Side Comparison

HemoShear Therapeutics Rubedo Life Sciences
Founded
2008 older 2018
Headquarters
Charlottesville, United States Sunnyvale, United States
Employees
27 32
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Debt Financing Series A
Total Funding
$54.95M $53.45M
Funding Rounds
8 7
Services
Not tracked yet Drug discovery and development, Clinical trials for anti-aging and chronic disease therapies, Research in biology of aging
Target Customers
Not tracked yet Patients with chronic diseases, Individuals seeking longevity and anti-aging solutions, Healthcare providers, Scientific researchers
Taxonomy
Drug Discovery, Metabolic Disorders, Rare Diseases, Human Disease Models, Tissue Engineering, Pharmaceutical Partnerships, Clinical Success, Genetic Defects, Liver Diseases, Treatment Development Biopharmaceutical, Drug Discovery, Senescent Cells, Chronic Diseases, Innovative Therapies, Small Molecules, Pulmonary Diseases, Dermatological Diseases, Oncological Diseases, Neurodegenerative Diseases, Fibrotic Diseases, Biotech Innovators, Sunnyvale, California, Drug Development
Website
hemoshear.com rubedolife.com
HemoShear Therapeutics logo

About HemoShear Therapeutics

HemoShear Therapeutics is a biotechnology company with a focus on developing new treatments for rare metabolic disorders. Established in 2008, the company utilizes a proprietary technology that allows them to recapitulate diseases using tissue from livers of children born with genetic defects. This...

Rubedo Life Sciences logo

About Rubedo Life Sciences

Rubedo Life Sciences, founded in 2018, is a promising player in the biotechnology, healthcare, and life sciences sectors. Headquartered in Sunnyvale, CA, this biopharmaceutical company is heralding a new era in age-related disease treatment with its pioneering approach. The company is known for its...

We will tell you when either one moves

BounceWatch watches HemoShear Therapeutics and Rubedo Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at HemoShear Therapeutics and Rubedo Life Sciences — by email.

Frequently Asked Questions

HemoShear Therapeutics — Developing new treatments for rare metabolic disorders. Rubedo Life Sciences — Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
HemoShear Therapeutics has raised $54.95M while Rubedo Life Sciences has raised $53.45M.
HemoShear Therapeutics and Rubedo Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare HemoShear Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at HemoShear Therapeutics on 12 Sep 2024, and Rubedo Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes